Chronic phencyclidine increases NMDA receptor NR1 subunit mRNA in rat forebrain

Cheng Wang, Vincent M. Showalter, Gilbert R. Hillman, Kenneth M. Johnson

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

The present study was designed to determine whether the sensitization of locomotor activity that results from chronic phencyclidine (PCP) administration is associated with altered NMDA receptor function or mRNA in rat brain. Female Sprague-Dawley rats were administered PCP (20 mg/kg, i.p.) once daily for 5 days. After withdrawal for 72 hr, challenge with 3.2 mg/kg PCP (i.p.) revealed a significant sensitization to the locomotor activating effect of PCP. In situ hybridization analysis with an oligonucleotide probe complementary to the mRNA encoding the NR1 subunit of the NMDA receptor demonstrated that chronic PCP treatment resulted in a marked increase in NR1 subunit mRNA in the forebrain. Quantitative image analysis revealed a significant increase in the labeling of NR1 mRNA in the olfactory tubercle, piriform cortex, frontal cortex, and anterior striatum. However, no significant difference between PCP and saline-treated rats was found in the hippocampus or cerebellum. In a parallel study, possible functional alterations in the NMDA receptor were assessed by measuring NMDA-stimulated release of [3H]DA from slices of the olfactory tubercle and piriform cortex. NMDA-stimulated release was not affected by chronic PCP treatment, but the inhibition of this release by PCP, 7-chlorokynurenic acid (7-CK), and DL-2- amino-5-phosphovaleric acid (AP-5) was significantly diminished by chronic PCP. This suggests that the behavioral plasticity associated with chronic PCP may be related to an altered subunit stoichiometry of NMDA receptors in selective forebrain regions.

Original languageEnglish (US)
Pages (from-to)762-769
Number of pages8
JournalJournal of Neuroscience Research
Volume55
Issue number6
DOIs
StatePublished - Mar 15 1999

Fingerprint

Phencyclidine
Prosencephalon
N-Methyl-D-Aspartate Receptors
Messenger RNA
N-Methylaspartate
Oligonucleotide Probes
Frontal Lobe
Locomotion
Cerebellum
In Situ Hybridization
Sprague Dawley Rats
Hippocampus
NR1 NMDA receptor
Brain
Piriform Cortex
Olfactory Tubercle

Keywords

  • Behavioral sensitization
  • Dopamine release
  • In situ hybridization
  • Olfactory tubercle
  • Phencyclidine

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Chronic phencyclidine increases NMDA receptor NR1 subunit mRNA in rat forebrain. / Wang, Cheng; Showalter, Vincent M.; Hillman, Gilbert R.; Johnson, Kenneth M.

In: Journal of Neuroscience Research, Vol. 55, No. 6, 15.03.1999, p. 762-769.

Research output: Contribution to journalArticle

Wang, Cheng ; Showalter, Vincent M. ; Hillman, Gilbert R. ; Johnson, Kenneth M. / Chronic phencyclidine increases NMDA receptor NR1 subunit mRNA in rat forebrain. In: Journal of Neuroscience Research. 1999 ; Vol. 55, No. 6. pp. 762-769.
@article{c7a74694542048e1b90afc5374c0eceb,
title = "Chronic phencyclidine increases NMDA receptor NR1 subunit mRNA in rat forebrain",
abstract = "The present study was designed to determine whether the sensitization of locomotor activity that results from chronic phencyclidine (PCP) administration is associated with altered NMDA receptor function or mRNA in rat brain. Female Sprague-Dawley rats were administered PCP (20 mg/kg, i.p.) once daily for 5 days. After withdrawal for 72 hr, challenge with 3.2 mg/kg PCP (i.p.) revealed a significant sensitization to the locomotor activating effect of PCP. In situ hybridization analysis with an oligonucleotide probe complementary to the mRNA encoding the NR1 subunit of the NMDA receptor demonstrated that chronic PCP treatment resulted in a marked increase in NR1 subunit mRNA in the forebrain. Quantitative image analysis revealed a significant increase in the labeling of NR1 mRNA in the olfactory tubercle, piriform cortex, frontal cortex, and anterior striatum. However, no significant difference between PCP and saline-treated rats was found in the hippocampus or cerebellum. In a parallel study, possible functional alterations in the NMDA receptor were assessed by measuring NMDA-stimulated release of [3H]DA from slices of the olfactory tubercle and piriform cortex. NMDA-stimulated release was not affected by chronic PCP treatment, but the inhibition of this release by PCP, 7-chlorokynurenic acid (7-CK), and DL-2- amino-5-phosphovaleric acid (AP-5) was significantly diminished by chronic PCP. This suggests that the behavioral plasticity associated with chronic PCP may be related to an altered subunit stoichiometry of NMDA receptors in selective forebrain regions.",
keywords = "Behavioral sensitization, Dopamine release, In situ hybridization, Olfactory tubercle, Phencyclidine",
author = "Cheng Wang and Showalter, {Vincent M.} and Hillman, {Gilbert R.} and Johnson, {Kenneth M.}",
year = "1999",
month = "3",
day = "15",
doi = "10.1002/(SICI)1097-4547(19990315)55:6<762::AID-JNR10>3.0.CO;2-E",
language = "English (US)",
volume = "55",
pages = "762--769",
journal = "Journal of Neuroscience Research",
issn = "0360-4012",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Chronic phencyclidine increases NMDA receptor NR1 subunit mRNA in rat forebrain

AU - Wang, Cheng

AU - Showalter, Vincent M.

AU - Hillman, Gilbert R.

AU - Johnson, Kenneth M.

PY - 1999/3/15

Y1 - 1999/3/15

N2 - The present study was designed to determine whether the sensitization of locomotor activity that results from chronic phencyclidine (PCP) administration is associated with altered NMDA receptor function or mRNA in rat brain. Female Sprague-Dawley rats were administered PCP (20 mg/kg, i.p.) once daily for 5 days. After withdrawal for 72 hr, challenge with 3.2 mg/kg PCP (i.p.) revealed a significant sensitization to the locomotor activating effect of PCP. In situ hybridization analysis with an oligonucleotide probe complementary to the mRNA encoding the NR1 subunit of the NMDA receptor demonstrated that chronic PCP treatment resulted in a marked increase in NR1 subunit mRNA in the forebrain. Quantitative image analysis revealed a significant increase in the labeling of NR1 mRNA in the olfactory tubercle, piriform cortex, frontal cortex, and anterior striatum. However, no significant difference between PCP and saline-treated rats was found in the hippocampus or cerebellum. In a parallel study, possible functional alterations in the NMDA receptor were assessed by measuring NMDA-stimulated release of [3H]DA from slices of the olfactory tubercle and piriform cortex. NMDA-stimulated release was not affected by chronic PCP treatment, but the inhibition of this release by PCP, 7-chlorokynurenic acid (7-CK), and DL-2- amino-5-phosphovaleric acid (AP-5) was significantly diminished by chronic PCP. This suggests that the behavioral plasticity associated with chronic PCP may be related to an altered subunit stoichiometry of NMDA receptors in selective forebrain regions.

AB - The present study was designed to determine whether the sensitization of locomotor activity that results from chronic phencyclidine (PCP) administration is associated with altered NMDA receptor function or mRNA in rat brain. Female Sprague-Dawley rats were administered PCP (20 mg/kg, i.p.) once daily for 5 days. After withdrawal for 72 hr, challenge with 3.2 mg/kg PCP (i.p.) revealed a significant sensitization to the locomotor activating effect of PCP. In situ hybridization analysis with an oligonucleotide probe complementary to the mRNA encoding the NR1 subunit of the NMDA receptor demonstrated that chronic PCP treatment resulted in a marked increase in NR1 subunit mRNA in the forebrain. Quantitative image analysis revealed a significant increase in the labeling of NR1 mRNA in the olfactory tubercle, piriform cortex, frontal cortex, and anterior striatum. However, no significant difference between PCP and saline-treated rats was found in the hippocampus or cerebellum. In a parallel study, possible functional alterations in the NMDA receptor were assessed by measuring NMDA-stimulated release of [3H]DA from slices of the olfactory tubercle and piriform cortex. NMDA-stimulated release was not affected by chronic PCP treatment, but the inhibition of this release by PCP, 7-chlorokynurenic acid (7-CK), and DL-2- amino-5-phosphovaleric acid (AP-5) was significantly diminished by chronic PCP. This suggests that the behavioral plasticity associated with chronic PCP may be related to an altered subunit stoichiometry of NMDA receptors in selective forebrain regions.

KW - Behavioral sensitization

KW - Dopamine release

KW - In situ hybridization

KW - Olfactory tubercle

KW - Phencyclidine

UR - http://www.scopus.com/inward/record.url?scp=0033559104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033559104&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-4547(19990315)55:6<762::AID-JNR10>3.0.CO;2-E

DO - 10.1002/(SICI)1097-4547(19990315)55:6<762::AID-JNR10>3.0.CO;2-E

M3 - Article

C2 - 10220116

AN - SCOPUS:0033559104

VL - 55

SP - 762

EP - 769

JO - Journal of Neuroscience Research

JF - Journal of Neuroscience Research

SN - 0360-4012

IS - 6

ER -